Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cenovus Energy Inc (CVE) vs Medtronic PLC (MDT) Price & Performance

Cenovus Energy IncTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

Cenovus Energy Inc vs Medtronic PLC — how do they compare? Cenovus Energy Inc trades at $31.38 (market cap $57.90B), while Medtronic PLC trades at $87.92 (market cap $112.24B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Cenovus Energy Inc for 46 Days and Medtronic PLC for 63 Days on average.

CVEMDT
Market Cap
$57.90B$112.24B
Volume
7,863,588105,663,236
Sector
EnergyHealth
52-Week High
$33.92$105.35
52-Week Low
$15.85$73.75
Typical Hold Time
46 Days63 Days
Enterprise Value
$63.84B$131.58B
Dividend Yield
1.97%3.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cenovus Energy Inc

Cenovus Energy (CVE) trades at $30.63, down 1.95% on the day, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a P/E of 12.14, EV/EBITDA of 6.03, and robust profitability metrics including 20.96% ROE. Recent analyst coverage shows 40.74% buy ratings, while technical indicators point to support near $30 with resistance at $31-32 levels. Cash flow trends indicate operational strength with $8.23B from operations in 2025.

CVE presents a mixed outlook with attractive valuation metrics and strong profitability offset by bearish technical signals. The company's projected 2026 revenue growth to $58B and net income of $6.7B suggests upside potential, though energy sector volatility and recent price weakness near key support levels warrant caution. Analyst consensus leans positive with limited sell-side coverage.

Medtronic PLC

Medtronic (MDT) trades at $85.51, down 1.81% on the day, showing bearish technical signals despite strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters with Q3 2026 results pending, while maintaining robust profitability margins of 65% gross and 14% net. Recent news highlights the company's 49-year dividend growth streak and new product approvals, though technical indicators show selling pressure with the stock trading near support at $85.

MDT presents a compelling value opportunity with a 3.2% dividend yield and 14% upside to the $97.80 consensus target, though near-term technical weakness and increasing debt levels warrant caution. The company's consistent earnings beats and medical device market leadership support long-term growth, while regulatory approvals for new systems provide catalysts.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVE
18% Buy82% Sell
Avg holding period · 46 Days
MDT
53% Buy47% Sell
Avg holding period · 63 Days

Top news

Latest headlines on both assets

About Cenovus Energy Inc

Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.

Read more on CVE →

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT →